Higher prevalence of diabetes in hypertensive subjects with upper body fat distribution

Revista de Investigacion Clinica

Volumn 50, Issue 1, 1998, Pages 5-12

  Escobedo de la Peña, Jorge ^a,b   Islas, Sergio ^a   Lifshitz Guinzberg, Alberto ^a   Méndez, José D ^a   Revilla, Cristina ^a   Vázquez Estupiñán, Felipe ^a  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b NONE   (Mexico)

Author keywords

Hypertension; Mexicans; Non insulin dependent diabetes mellitus; Risk factors; Upper body fat distribution

Indexed keywords

ADIPOSE TISSUE; ADULT; AGED; ARTICLE; BLOOD PRESSURE; BODY MASS; COMORBIDITY; CROSS-SECTIONAL STUDY; FEMALE; GENETICS; GLUCOSE BLOOD LEVEL; HISTOLOGY; HUMAN; HYPERTENSION; INSULIN RESISTANCE; MALE; MEXICO; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PREVALENCE; RISK FACTOR; SKINFOLD THICKNESS; SOMATOTYPE; SYNDROME;

ADIPOSE TISSUE; ADULT; AGED; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; COMORBIDITY; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPERTENSION; INSULIN RESISTANCE; MALE; MEXICO; MIDDLE AGED; OBESITY; PREVALENCE; RISK FACTORS; SKINFOLD THICKNESS; SOMATOTYPES; SYNDROME;

EID: 0031643789     PISSN: 00348376     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. DeFronzo RA, Ferrannini E. Insulin resistance: a multifaceted syndrome responsible of NIDDM, obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular disease. Diab Care 1991; 14:173-94.
2. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37:1595-607.
3. Vázquez-Robles M, Romero-Romero E, Escandón-Romero C, Escobedo-de la Peña J. Prevalencia de diabetes mellitus no insulinodependiente y factores de riesgo asociados en una población de México, DF. Gac Med Mex 1993; 129:191-9.
4. Posadas-Romero C, Yamamoto-Kimura L, Lerman-Garber I, Zamora González J, Fajardo-Gutiérrez A, Velázquez L, et al. The prevalence of NIDDM and associated coronary risk factors in Mexico City. Diab Care 1994; 17:1441-8.
5. Stern MP, González C, Mitchell BD, Villalpando E, Haffner SM, Hazuda HP. Genetic and environmental determinants of type II diabetes in Mexico City and San Antonio. Diabetes 1992; 41:484-92.
6. Morales PA, Mitchell BD, Valdez RA, Hazuda HP, Stern MP, Haffner SM. Incidence of NIDDM and impaired glucose tolerance in hypertensive subjects. The San Antonio heart study. Diabetes 1993; 42:154-61.
7. Barrett-Connor E. Epidemiology, obesity, and non-insulin-dependent diabetes mellitus. Epidemiol Rev 1989; 11:172-81.
8. Mueller WH, Wear ML, Hanis CL, Emerson JB, Barton SA, Hewett-Emmett D, et al. Wich measure of body fat distribution is best for epidemiologic research? Am J Epidemiol 1991; 133:858-69.
9. WHO Study Group on Diabetes Mellitus. Technical Report Series 727. Geneva: World Health Organization; 1985.
10. Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V). Arch Intern Med 1993; 153:154-83.
11. King H, Rewers M, WHO Ad Hoc Diabetes Reporting Group. Global estimates for prevalence of diabetes mellitus and impaired glucose tolerance in adults. Diab Care 1993; 16:157-77.
12. Rothman KJ. Interaction between causes. In: Modern Epidemiology. Boston: Little Brown; 1986:311-26.
13. Ferrannini E, Buzzigoli G, Bonadonna R, Giorico MA, Oleggini M, Graziadei L, et al. Insulin resistance in essential hypertension. N Engl J Med 1987; 317:350-7.
14. Ferrannini E, Natali A. Essential hypertension, metabolic disorders, and insulin resistance. Am Heart J 1991; 121:1274-82.
15. Pollare T, Lithell H, Berne C. Insulin resistance is a characteristic feature of primary hypertension independent of obesity. Metabolism 1990; 39:167-74.
16. Taylor SI, Accili D, Imai Y. Insulin resistance or insulin deficiency. Wich is the primary cause of NIDDM? Diabetes 1994; 43:73540.
17. DeFronzo RA, Bonadonna RC, Ferrannini E. Pathogenesis of NIDDM. Diab Care 1992; 15:318-68.
18. Kissebah AH, Krakower GR. Regional adiposity and morbidity. Physiol Rev 1994; 74:761-811.
19. Kissebah AH, Vydelingum N, Murray R; Evans DJ, Hartz AJ, Kalkhoff RK, et al. Relation of body fat distribution to metabolic complications of obesity. J Clin Endocrinol Metab 1982; 54:254-60.
20. Hartz AJ, Rupley DC, Kalkhoff RD, Rimm AA. Relationship of obesity to diabetes; influence of obesity level and body fat distribution. Prev Med 1983; 12:351-7.
21. Maheux P, Jeppesen J, Sheu WHH, Hollenbeck CB, Clinkingbeard C, Greenfield MS, et al. Additive effects of obesity, hypertension, and type 2 diabetes on insulin resistance. Hypertension 1994; 24:695-8.
22. Laakso M, Sarlund H, Mykkänen L. Essential hypertension and insulin resistance in non-insulin-dependent diabetes. Eur J Clin Invest 1989; 19:518-26.
23. Ghannem H, Maarouf R, Tabka A, Haj Frej A, Marzouki M. La triade de obesité, hypertension et troubles de la glycoregulation dans une population semi-urbaine du Sahel Tunisien. Diabete Metab 1993; 19:310-4.
24. Bonora E, Bonadonna RC, Del Prato S, Gulli G, Solini A, Matsuda M, et al. In vivo glucose metabolism in obese and type II diabetic subjects with or whithout hypertension. Diabetes 1993; 42:764-72.
25. Berdanier CD, Pan JS, Hartle DK, Michaelis OE IV. Glucose turnover in lean and obese rats of the SHR/N-cp and LA/N-cp strains. Comp Biochem Physiol (B) 1993; 106: 87-94.
26. Mills E, Kuhn CM, Feinglos MN, Surwit R. Hypertension in CB57BL/6J mouse model of non-insulin-dependent diabetes mellitus. Am J Physiol 1993; 264:R73-8.